Sponsors
For information on Sponsor opportunities, please contact the Sponsorship Department SponsorEKS@oic.it.

EKS 2025 has received a COMPLIANT assessment by Ethical MedTech Europe (EMT-25-03900).
MedTech Europe Code of Ethical Business Practice regulates all aspects of the industry’s relationship with Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) such as: company organised events, arrangements with consultants, research and financial support to medical education, amongst others. It also introduces an independent enforcement mechanism.
From 1 January 2018, MedTech Europe Member Companies and their representatives no longer permit to provide direct financial support to individual HCPs from the MedTech Europe Geographic area, which includes EU and EEA countries as well as Russia, Turkey and the countries governed by Mecomed to attend Third-Party Organised Events.
Support to medical education offered to Third Party Organised Events must be provided through Educational Grants given to HCOs, such as scientific societies, hospitals or foundations or Professional Congress Organisers (PCOs). The selection of the beneficiaries of these Grants must be the sole responsibility of the HCO/PCO receiving the Educational Grant.
Companies that are interested in granting an Educational Support for EKS 2025 are welcome to contact sponsorEKS@oic.it.
DIAMOND
Orthopaedic solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges.
In Orthopaedics, we are on a mission to keep people moving by leveraging our deep expertise in joint reconstruction, robotics and enabling tech, spine, sports, trauma, and extremities, to develop the next generation of medtech solutions. We offer one of the most comprehensive Orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve.
For more, visit https://www.jnjmedtech.com/en-EMEA/companies/depuy-synthes
Orthopaedics
Orthopaedics includes an innovative range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and Trauma products used to stabilise severe fractures and correct bone deformities.
Our Hip and Knee Implant portfolio includes products made from OXINIUM, an advanced load bearing technology created through a proprietary manufacturing process. We believe that OXINIUM exhibits unique performance characteristics due to its hardness, low-friction and resistance to roughening and abrasion.
For more information about Enovis, please visit our website.
Orthopaedic solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges.
In Orthopaedics, we are on a mission to keep people moving by leveraging our deep expertise in joint reconstruction, robotics and enabling tech, spine, sports, trauma, and extremities, to develop the next generation of medtech solutions. We offer one of the most comprehensive Orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve.
For more, visit https://www.jnjmedtech.com/en-EMEA/companies/depuy-synthes
Orthopaedics
Orthopaedics includes an innovative range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and Trauma products used to stabilise severe fractures and correct bone deformities.
Our Hip and Knee Implant portfolio includes products made from OXINIUM, an advanced load bearing technology created through a proprietary manufacturing process. We believe that OXINIUM exhibits unique performance characteristics due to its hardness, low-friction and resistance to roughening and abrasion.
TITANIUM
We’re Enovis – a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life.
We strive to make each day better by partnering with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. We do this through our extraordinary talent, a relentless focus on innovation, strategic acquisitions, and a common culture of continuous improvement.
With more than 7,000 extraordinary employees worldwide and an extensive range of products, services, and integrated technologies our solutions impact the well-being of millions of patients wherever they are on their pathway to health.
For more information about Enovis, please visit enovis.com.
EXHIBITORS
Medacta is a global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries.
Visit our website www.medacta.com.